$140M Verdict Against AbbVie In Testosterone MDL Tossed

Law360 (July 5, 2018, 5:50 PM EDT) -- An Illinois federal judge vacated a $140 million verdict against AbbVie Inc. from the second bellwether in multidistrict litigation over testosterone products on Thursday, saying the jury's finding for the company on the case's strict liability claim threw a wrench in the rest of its verdict.

U.S. District Judge Matthew Kennelly agreed with the Illinois-based pharmaceutical company that the jury's finding for AbbVie on strict liability at the end of the October trial clashed with its finding for plaintiff Jeffrey Konrad on his negligence claim. He vacated the judgment and ordered a new trial on all claims, saying the inconsistency required...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!